Oncology News | pharmaphorum

News

Novartis' Basel HQ: the company is looking for more blockbusters to lift revenues

Novartis posts modest growth as Narasimhan takes charge

Swiss pharma giant Novartis saw modest growth of 2% in 2017, with growth in Cosentyx and Entresto offsetting generic erosion to its cancer blockbuster Gleevec/Glivec.

News

AZ's cancer and respiratory drugs approved in Japan

Two AstraZeneca (AZ) drugs have been approved in Japan – its cancer drug Lynparza and its respiratory drug Fasenra.

News

AI-backed blood test could reduce reliance on cancer drugs

Approach could reduce use of cancer drugs.

News

Biocon and Sandoz strike biosimilars partnership

Companies will develop and market several biosimilars

News

NICE backs interim funding for Janssen cancer drug

NICE has recommended that Janssen’s Darzalex (daratumumab) should be reimbursed on an interim basis by the Cancer Drugs Fund in pre-treated multiple myeloma, after months of wrangling.

News